Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

EVA Basel

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 6
Average round size
info
The average size of a deal this fund participated in
$2M
Portfolio companies 5
Rounds per year 0.23
Lead investments 3
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.17
Key employees Soon
Stages of investment
Early Stage Venture
Seed

Areas of investment

  • Biotechnology
  • Pharmaceutical
  • Medical Device
  • Medical
  • Communities
Summary

EVA Basel appeared to be the Corporate Investor, which was created in 1996. The main department of described Corporate Investor is located in the Basel. The company was established in Europe in Switzerland.

The standard case for the fund is to invest in rounds with 2-3 partakers. Despite the EVA Basel, startups are often financed by Venture Kick, Zu00fcrcher Kantonal Bank, Neuromuscular Research Association Basel. The meaningful sponsors for the fund in investment in the same round are Zu00fcrcher Kantonal Bank, StartAngels Network, Redalpine Venture Partners. In the next rounds fund is usually obtained by Zu00fcrcher Kantonal Bank, SHS Gesellschaft fur Beteiligungsmanagement, Novo Seeds.

For fund there is a match between the country of its foundation and the country of its the most frequent investments - Switzerland. Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund. We can highlight the next thriving fund investment areas, such as Robotics, Manufacturing. Among the various public portfolio startups of the fund, we may underline Memo Therapeutics, AOT - Advanced Osteotomy Tools, BioVersys AG The fund has exact preference in some founders of portfolio startups. In case when startup counts 4 or 5+ of the founder, the chance for it to get the investment is meager.

Considering the real fund results, this Corporate Investor is 30 percentage points more often commits exit comparing to other organizations. Deals in the range of 1 - 5 millions dollars are the general things for fund. The fund is constantly included in less than 2 deals per year. The high activity for fund was in 2015.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of EVA Basel:
Typical Co-investors
EVA Basel is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after EVA Basel:
There are no funds here. If we find new data, we will add it here.

Funds with similar focus

Funds from Switzerland
Funds with similar focus located in Switzerland:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
1to1 Venture Partners Connecticut, Stamford, United States
Continuity Capital Australia, Australian Capital Territory, Canberra
Elephant Capital England, London, United Kingdom
Elscint Biomedical Investment -
FreshDirect Long Island City, New York, United States
Heritage Provider Network California, Northridge, United States
Invictus Advisory Group -
Kiwi II Venture Capital -
Phyto Partners Boca Raton, Florida, United States
Plutus Capital New York, New York, United States
Real Tech Fund Japan, Sumida
Solon Arizona, Tucson, United States
Special Equities Group -
Sports Industrial Fund of Zhejiang Province -
The Contrarian Group California, Newport Beach, United States
UGFS Gabès, Tunis, Tunisia
University Hospitals Cleveland, Ohio, United States
Wharton Capital New York, New York, United States
Yangli Konggu China, Liaoning, Shenyang

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

POLYNEURON

Biotechnology
Communities
Medical
Medical Device
$3M14 May 2018 Basel, Basel-City, Switzerland

POLYNEURON

Biotechnology
Communities
Medical
Medical Device
$3M12 May 2016 Basel, Basel-City, Switzerland

Inthera Bioscience

Biotechnology
Pharmaceutical
$4M14 Dec 2015 Zurich, Switzerland

Memo Therapeutics

Biotechnology
Collaboration
$2M22 Jul 2015 Zurich, Zurich, Switzerland

AOT - Advanced Osteotomy Tools

Manufacturing
Medical Device
Navigation
Pharmaceutical
Robotics
$1M25 Jan 2012 Basel, Basel-City, Switzerland

BioVersys

Biotechnology
Drug Discovery
Pharmaceutical
Pharmaceuticals
$2M31 Mar 2011 Basel, Basel-City, Switzerland

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent EVA Basel?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 6
Average round size 2M
Rounds per year 0.23
Peak activity year 2015
Lead investments 3
Follow on index 0.17
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

POLYNEURON

Biotechnology
Communities
Medical
Medical Device
$3M14 May 2018 Basel, Basel-City, Switzerland

POLYNEURON

Biotechnology
Communities
Medical
Medical Device
$3M12 May 2016 Basel, Basel-City, Switzerland

Inthera Bioscience

Biotechnology
Pharmaceutical
$4M14 Dec 2015 Zurich, Switzerland

Memo Therapeutics

Biotechnology
Collaboration
$2M22 Jul 2015 Zurich, Zurich, Switzerland

AOT - Advanced Osteotomy Tools

Manufacturing
Medical Device
Navigation
Pharmaceutical
Robotics
$1M25 Jan 2012 Basel, Basel-City, Switzerland

BioVersys

Biotechnology
Drug Discovery
Pharmaceutical
Pharmaceuticals
$2M31 Mar 2011 Basel, Basel-City, Switzerland
Crunchbase icon

Content report

The following text will be sent to our editors: